SciELO - Scientific Electronic Library Online

 
vol.27 issue5Esophageal Mucosal Bridge of Unknown Etiology Causing Dysphagia in an Elderly Female: Endoscopic Management and Literature ReviewCytomegalovirus Colitis Mimicking Rectal Tumour in an Undiagnosed HIV Patient author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


GE-Portuguese Journal of Gastroenterology

Print version ISSN 2341-4545

Abstract

SILVA, Joana Inês Alves da; CAETANO, Cidalina  and  PEDROTO, Isabel. Azathioprine-Induced Acute Submandibular Sialadenitis in a Crohn’s Disease Patient. GE Port J Gastroenterol [online]. 2020, vol.27, n.5, pp.361-363. ISSN 2341-4545.  https://doi.org/10.1159/000505037.

Introduction: Azathioprine (AZA) is a widely used immunosuppressive drug in inflammatory bowel disease (IBD). The occurrence of adverse effects (AEs) is a major downside in the use of this drug, leading to treatment withdrawal in a variable proportion of patients. Case Presentation: We report the case of a Crohn’s disease patient who developed sialadenitis as an AE to AZA. Discussion and Conclusion: To our knowledge this AE has been reported only once in the literature. Sialadenitis is a common disorder and refers to inflammation of a salivary gland. It has many causes, such as bacterial and viral infections, ductal obstruction, and drugs. There are several AEs related to this drug, categorized as dose-dependent and dose-independent. Their knowledge is essential for therapeutic management in IBD, which is already challenging, requiring an individualized approach.

Keywords : Azathioprine; Adverse effect; Sialadenitis; Crohn’s disease.

        · abstract in Portuguese     · text in English     · English ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License